{"id":"https://openalex.org/W2000299043","doi":"https://doi.org/10.3389/fonc.2014.00270","title":"Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells","display_name":"Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells","publication_year":2014,"publication_date":"2014-10-06","ids":{"openalex":"https://openalex.org/W2000299043","doi":"https://doi.org/10.3389/fonc.2014.00270","mag":"2000299043","pmid":"https://pubmed.ncbi.nlm.nih.gov/25340039","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4186483"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2014.00270","doi":"https://doi.org/10.3389/fonc.2014.00270","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2014.00270","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2014.00270/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2014.00270/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Matjaz Humar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161046081","display_name":"University of Freiburg","ror":"https://ror.org/0245cg223","country_code":"DE","type":"education","lineage":["https://openalex.org/I161046081"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Matjaz Humar","raw_affiliation_strings":["Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University of Freiburg , Freiburg , Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University of Freiburg , Freiburg , Germany","institution_ids":["https://openalex.org/I161046081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111590385","display_name":"Marc Az\u00e9mar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc Azemar","raw_affiliation_strings":["Internistische Onkologie, Tumor Biology Center , Freiburg , Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internistische Onkologie, Tumor Biology Center , Freiburg , Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110014825","display_name":"Martina Maurer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martina Maurer","raw_affiliation_strings":["Basilea Pharmaceutica International Ltd. , Basel , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica International Ltd. , Basel , Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110047411","display_name":"Bernd Groner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bernd Groner","raw_affiliation_strings":["Institute for Biomedical Research, Georg Speyer Haus , Frankfurt am Main , Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Biomedical Research, Georg Speyer Haus , Frankfurt am Main , Germany","institution_ids":["https://openalex.org/I4210153469"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161046081"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.2748,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.53229845,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":94},"biblio":{"volume":"4","issue":null,"first_page":"270","last_page":"270"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.6019999980926514},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.8479999899864197},{"id":"https://openalex.org/keywords/tumor-antigen-expression","display_name":"tumor antigen expression","score":0.6110000014305115},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.6919999718666077},{"id":"https://openalex.org/keywords/dendritic-cell-vaccine","display_name":"dendritic cell vaccine","score":0.5830000042915344},{"id":"https://openalex.org/keywords/t-cell-dependent-immune-response","display_name":"T cell-dependent immunity","score":0.6629999876022339},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.6700000166893005},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.984000027179718},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.5},{"id":"https://openalex.org/keywords/tumor-suppressor-mutations","display_name":"tumor suppressor mutations","score":0.3089999854564667}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6272056102752686},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6224238872528076},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.59034264087677},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5688069462776184},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5335128307342529},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5305353403091431},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.5125886797904968},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5025100708007812},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4834457337856293},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4532436430454254},{"id":"https://openalex.org/C2776495794","wikidata":"https://www.wikidata.org/wiki/Q1362453","display_name":"Fibrosarcoma","level":2,"score":0.43758174777030945},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.41651245951652527},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06878086924552917},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fonc.2014.00270","doi":"https://doi.org/10.3389/fonc.2014.00270","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2014.00270","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2014.00270/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:25340039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25340039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4186483","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4186483/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3cb08dff3afd49778809f9b8a53d033b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3cb08dff3afd49778809f9b8a53d033b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 4 (2014)","raw_type":"article"},{"id":"pmh:oai:publikationen.ub.uni-frankfurt.de:35402","doi":null,"is_oa":true,"landing_page_url":"http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/35402","pdf_url":null,"source":{"id":"https://openalex.org/S4306400432","display_name":"Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114090438","host_organization_name":"Goethe University Frankfurt","host_organization_lineage":["https://openalex.org/I114090438"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2014.00270","doi":"https://doi.org/10.3389/fonc.2014.00270","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2014.00270","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2014.00270/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323556","display_name":"Deutsche Krebshilfe","ror":"https://ror.org/01wxdd722"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000299043.pdf","grobid_xml":"https://content.openalex.org/works/W2000299043.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W1732481302","https://openalex.org/W1968950760","https://openalex.org/W1974657308","https://openalex.org/W1976750616","https://openalex.org/W1983986735","https://openalex.org/W1984677655","https://openalex.org/W1990484467","https://openalex.org/W1990679166","https://openalex.org/W1991331687","https://openalex.org/W1997341897","https://openalex.org/W2000821132","https://openalex.org/W2014985358","https://openalex.org/W2020543365","https://openalex.org/W2021087717","https://openalex.org/W2027741075","https://openalex.org/W2033970156","https://openalex.org/W2035595523","https://openalex.org/W2039138842","https://openalex.org/W2044227662","https://openalex.org/W2047766643","https://openalex.org/W2050216284","https://openalex.org/W2052638948","https://openalex.org/W2052874737","https://openalex.org/W2055882469","https://openalex.org/W2062254683","https://openalex.org/W2062414686","https://openalex.org/W2062571451","https://openalex.org/W2063372741","https://openalex.org/W2072505354","https://openalex.org/W2074992368","https://openalex.org/W2075772957","https://openalex.org/W2084596426","https://openalex.org/W2084831115","https://openalex.org/W2089408144","https://openalex.org/W2090789725","https://openalex.org/W2097995306","https://openalex.org/W2104401164","https://openalex.org/W2107491761","https://openalex.org/W2121808021","https://openalex.org/W2127094135","https://openalex.org/W2134007339","https://openalex.org/W2135808990","https://openalex.org/W2136527924","https://openalex.org/W2139900585","https://openalex.org/W2142959209","https://openalex.org/W2143043043","https://openalex.org/W2143529834","https://openalex.org/W2144277728","https://openalex.org/W2152865079","https://openalex.org/W2157120289","https://openalex.org/W2244032147","https://openalex.org/W2282927702","https://openalex.org/W2313365286","https://openalex.org/W2418722754","https://openalex.org/W4235301164","https://openalex.org/W4255758041","https://openalex.org/W6695608891"],"related_works":["https://openalex.org/W7096902960","https://openalex.org/W2317574355","https://openalex.org/W2123554111","https://openalex.org/W2565928120","https://openalex.org/W1971038274","https://openalex.org/W4409691364","https://openalex.org/W2397529130","https://openalex.org/W1924603736","https://openalex.org/W1484295404","https://openalex.org/W2168739618"],"abstract_inverted_index":{"Immunotherapy":[0],"of":[1,13,21,43,80,123,136,141,180,191,215,223,231,241,267],"cancer":[2,216],"utilizes":[3],"dendritic":[4,34],"cells":[5,36,63,69,105],"(DCs)":[6],"for":[7,260],"antigen":[8],"presentation":[9],"and":[10,89,93,103,109,152,160,187,255],"the":[11,18,44,178,221,229,239,265,270],"induction":[12,20,222],"tumor-specific":[14],"immune":[15,95,163,235,248,272],"responses.":[16],"However,":[17,119],"therapeutic":[19,108],"anti-tumor":[22,94,226],"immunity":[23,113],"is":[24],"limited":[25],"by":[26,218,250],"tumor":[27,46,58,68,91,112,127,154,158,172,201,232],"escape":[28,249],"mechanisms.":[29],"In":[30,60,237],"this":[31],"study,":[32],"immortalized":[33],"D2SC/1":[35,62,151],"were":[37,64,84,97,196],"transduced":[38],"with":[39,66,146,206],"a":[40,72,77,121,212,224,251,257],"mutated":[41],"version":[42],"p53":[45,142],"suppressor":[47],"gene,":[48],"p53M234I,":[49],"or":[50,193],"p53C132F/E168G,":[51],"which":[52],"are":[53],"overexpressed":[54],"in":[55,99,116,120,177],"MethA":[56,67,90,111,126,153,157,171,200],"fibrosarcoma":[57],"cells.":[59],"addition,":[61],"fused":[65],"to":[70],"generate":[71],"vaccine":[73],"that":[74,220],"potentially":[75],"expresses":[76],"large":[78],"repertoire":[79],"tumor-antigens.":[81],"Cellular":[82],"vaccines":[83],"transplanted":[85],"onto":[86],"Balb/c":[87,117,188],"mice":[88,125,186,189],"growth":[92,128,159,203],"responses":[96,167],"examined":[98],"vaccinated":[100],"animals.":[101],"D2SC/1-p53M234I":[102],"D2SC/1-p53C132F/E168G":[104],"induced":[106],"strong":[107],"protective":[110],"upon":[114],"transplantation":[115],"mice.":[118,183],"fraction":[122],"immunized":[124],"resumed":[129],"after":[130,204],"an":[131],"extended":[132],"latency":[133],"period.":[134],"Analysis":[135],"these":[137],"tumors":[138],"indicated":[139],"loss":[140],"expression.":[143],"Mice,":[144],"pre-treated":[145],"fusion":[147,244],"hybrids":[148,245],"generated":[149],"from":[150],"cells,":[155],"suppressed":[156],"averted":[161],"adaptive":[162,247],"escape.":[164],"Polyclonal":[165],"B-cell":[166],"directed":[168],"against":[169,199],"various":[170],"proteins":[173],"could":[174],"be":[175],"detected":[176],"sera":[179],"D2SC/1-MethA":[181,207],"inoculated":[182],"Athymic":[184],"nude":[185],"depleted":[190],"CD4(+)":[192],"CD8(+)":[194],"T-cells":[195],"not":[197],"protected":[198],"cell":[202,243],"immunization":[205],"hybrids.":[208],"Our":[209],"results":[210],"highlight":[211],"potential":[213],"drawback":[214],"immunotherapy":[217],"demonstrating":[219],"specific":[225],"response":[227],"favors":[228],"acquisition":[230],"phenotypes":[233],"promoting":[234],"evasion.":[236],"contrast,":[238],"application":[240],"DC/tumor":[242],"prevents":[246],"T-cell":[252],"dependent":[253],"mechanism":[254],"provides":[256],"simple":[258],"strategy":[259],"personalized":[261],"anti-cancer":[262],"treatment":[263],"without":[264],"need":[266],"selectively":[268],"priming":[269],"host":[271],"system.":[273]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}